Table 1 Statistical Analysis of... | American Society of Hematology

Table 1

Table 1. Statistical Analysis of Rituximab Pharmacokinetic Primary Endpoints for Core Cycle 4 at Steady State: Pharmacokinetic Population

Statistical Analysis of Rituximab Pharmacokinetic Primary Endpoints for Core Cycle 4 at Steady State: Pharmacokinetic Population

This Feature Is Available To Subscribers Only

Sign In or Create an Account